# Corrigendum to “Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028”: [ESMO Open 10 (2025) 104295]

**Authors:** M. Donia, H. Jespersen, M. Jalving, R. Lee, H. Eriksson, C. Hoeller, M. Hernberg, I. Gavrilova, L. Kandolf, G. Liszkay, H. Helgadottir, A. Zhukavets, D. Pjanova, I. Marquez-Rodas, B. Neyns, H. Westgeest, I. Pourmir, P. Sobczuk, E. Ellebaek, T. Amaral

PMC · DOI: 10.1016/j.esmoop.2025.105492 · 2026-01-02

## Full-text entities

- **Diseases:** melanoma (MESH:D008545)

---
Source: https://tomesphere.com/paper/PMC12805333